Search results for "insulin"

showing 10 items of 1360 documents

The Effects of Sympathetic Inhibition on Metabolic and Cardiopulmonary Responses to Exercise in Hypoxic Conditions.

2015

Objective Pre-exertion skeletal muscle glycogen content is an important physiological determinant of endurance exercise performance: low glycogen stores contribute to premature fatigue. In low-oxygen environments (hypoxia), the important contribution of carbohydrates to endurance performance is further enhanced as glucose and glycogen dependence is increased; however, the insulin sensitivity of healthy adult humans is decreased. In light of this insulin resistance, maintaining skeletal muscle glycogen in hypoxia becomes difficult, and subsequent endurance performance is impaired. Sympathetic inhibition promotes insulin sensitivity in hypoxia but may impair hypoxic exercise performance, in p…

AdultMalemedicine.medical_specialtySympathetic nervous systemCardiac outputBlood PressureClonidinechemistry.chemical_compoundInsulin resistanceEndurance trainingHeart RateInternal medicinemedicineHumansHypoxiaExerciseGlycogenbusiness.industryPublic Health Environmental and Occupational HealthVO2 maxSkeletal muscleHypoxia (medical)medicine.diseaseEndocrinologymedicine.anatomical_structurechemistryOxyhemoglobinsEmergency MedicineExercise TestPhysical EnduranceSympatholyticsmedicine.symptombusinessWildernessenvironmental medicine
researchProduct

Atherogenic lipoprotein phenotype and low-density lipoprotein size and subclasses in patients with growth hormone deficiency before and after short-t…

2007

Objective: Patients with growth hormone deficiency (GHD) have increased cardiovascular risk and may show elevated triglyceride and reduced high density lipoprotein (HDL) cholesterol concentrations, two lipid abnormalities usually accompanied by increased small dense LDL in the ‘atherogenic lipoprotein phenotype’ (ALP). In the present study, we directly investigated (1) whether hypopituitary patients with GHD have increased small dense LDL; (2) whether growth hormone replacement therapy (GHRT) beneficially impact on such particles; (3) the prevalence of ALP in GHD and GHRT patients. Design and methods: In 14 hypopituitary patients with GHD (44 ± 13 years, body mass index (BMI) 27 ± 3) before…

AdultMalemedicine.medical_specialtyTime FactorsArteriosclerosisHormone Replacement TherapyEndocrinology Diabetes and MetabolismBiologyHypopituitarismGrowth hormone deficiencychemistry.chemical_compoundEndocrinologyInternal medicinemedicineHumansIn patientInsulin-Like Growth Factor ITriglyceridesTriglycerideHuman Growth HormoneCholesterolVascular diseaseCholesterol HDLGeneral MedicineMiddle AgedAtherogenic lipoprotein phenotypemedicine.diseaseLipoproteins LDLCholesterolTreatment OutcomeEndocrinologyAtheromachemistryLow-density lipoproteinElectrophoresis Polyacrylamide GelFemalelipids (amino acids peptides and proteins)European Journal of Endocrinology
researchProduct

Effect of Cabergoline on Metabolism in Prolactinomas.

2013

<b><i>Introduction:</i></b> Hyperprolactinemia has been implicated in the pathogenesis of obesity and glucose intolerance and is reportedly associated with an impaired metabolic profile. The current study aimed at investigating the effects of 12- and 60-month treatment with cabergoline (CAB) on metabolic syndrome (MetS) in patients with prolactinomas. <b><i>Patients and Methods:</i></b> 61 patients with prolactinomas (13 men, 48 women, 41 with microadenoma, 20 with macroadenoma), aged 34.4 ± 10.3 years, entered the study. In all patients, prolactin (PRL) and metabolic parameters were assessed at diagnosis and after 12 and 60 months of continuo…

AdultMalemedicine.medical_specialtyTime FactorsEndocrinology Diabetes and MetabolismTreatment outcomeprolactinomasAntineoplastic AgentsSettore MED/13 - EndocrinologiaPathogenesisCellular and Molecular NeuroscienceEndocrinologyInsulin resistanceMetabolic DiseasesCabergolineInternal medicinePrevalenceMedicineHumansInsulinPituitary NeoplasmsProspective StudiesErgolinesAdiposityMetabolic SyndromeDose-Response Relationship DrugEndocrine and Autonomic Systemsbusiness.industryPituitary tumorsMetabolismFastingmedicine.diseasePrognosisProlactinProlactinHyperprolactinemiaEndocrinologyTreatment OutcomeprolactinomacabergolineFemaleMetabolic syndromeInsulin Resistancebusinessmetabolismmedicine.drug
researchProduct

Protein Ingestion Prior to Strength Exercise Affects Blood Hormones and Metabolism

2005

HULMI, J. J., J. S. VOLEK, H. SELANNE, and A. A. MERO. Protein Ingestion Prior to Strength Exercise Affects Blood Hormones and Metabolism. Med. Sci. Sports Exerc., Vol. 37, No. 11, pp. 1990 -1997, 2005. Purpose: The effects of protein consumption before strength training session on blood hormones, energy metabolites, RER, and excess postexercise oxygen consumption (EPOC) were examined. Methods: Ten resistance-trained young men consumed either a 25 g of whey and caseinate proteins (PROT) or a noncaloric placebo (P) in a liquid form 30 min before a heavy strength training session (STS) in a crossover design separated by at least 7 d. STS lasted 50 min and included 5 1 RM squats, 3 10 RM squat…

AdultMalemedicine.medical_specialtyTime FactorsWeight LiftingStrength trainingmedicine.medical_treatmentPhysical Therapy Sports Therapy and RehabilitationPhysical exercisePlacebosOxygen ConsumptionInternal medicinemedicineHumansInsulinIngestionTestosteroneOrthopedics and Sports MedicinePancreatic hormoneCross-Over StudiesHuman Growth HormoneChemistryInsulinFatty AcidsVenous bloodMilk ProteinsCrossover studyWhey ProteinsEndocrinologyArea Under CurveDietary ProteinsOxidation-ReductionHormoneMedicine & Science in Sports & Exercise
researchProduct

Association of Serum Retinol Binding Protein 4 with Atherogenic Dyslipidemia in Morbid Obese Patients

2013

Retinol binding protein 4 (RBP4) is an adipokine that may contribute to the development of insulin resistance. However, how this adipokine is affected and its possible involvement in lipid metabolism in obese patients with varying degrees of insulin resistance is yet to be determined. A total of 299 middle-aged morbid obese patients (BMI>40 kg/m(2)) were divided in euglycemic, metabolic syndrome or type 2 diabetic. Anthropometric measurements, biochemical variables and systemic RBP4 levels were determined. RBP4 levels were significantly higher in patients with metabolic syndrome and type 2 diabetes than in euglycemic subjects (42.9±14.6; 42.3±17.0 and 37.4±11.7 µg/ml, respectively) and corr…

AdultMalemedicine.medical_specialtyVery low-density lipoproteinScienceCholesterol VLDLAdipokineType 2 diabetesBody Mass Indexchemistry.chemical_compoundInsulin resistanceInternal medicinemedicineHumansTriglyceridesDyslipidemiasMetabolic SyndromeRetinol binding protein 4MultidisciplinarybiologyCholesterolbusiness.industryCholesterol HDLQRCholesterol LDLMiddle AgedAtherosclerosisLipid Metabolismmedicine.diseaseObesity MorbidRetinol binding proteinEndocrinologyDiabetes Mellitus Type 2chemistryMultivariate Analysisbiology.proteinMedicineFemaleInsulin ResistanceMetabolic syndromebusinessRetinol-Binding Proteins PlasmaResearch ArticlePLoS ONE
researchProduct

Circulating IGF-I is associated with fitness and health outcomes in a population of 846 young healthy men

2011

Abstract Context Insulin-like growth factor-I (IGF-I) is thought to mediate many of the beneficial outcomes of physical activity. While IGF-I has previously been shown to be positively related with aerobic fitness, few studies have examined IGF-I relationships with other fitness and health parameters. The robustness of IGF-I as a biomarker of fitness and health has yet to be fully determined. Objective To determine the association of circulating IGF-I with fitness, body composition and health parameters in young, healthy men. Design and subjects A cross-section of 846 young, healthy Finnish men (25 ± 5 yr, 180 ± 6 cm, 81 ± 13 kg). Subjects were divided into quintiles of IGF-I concentrations…

AdultMalemedicine.medical_specialtyWaistEndocrinology Diabetes and MetabolismPhysical fitnessPopulationBench pressBody Mass Indexchemistry.chemical_compoundEndocrinologyInternal medicinemedicineHumansAerobic exerciseMuscle StrengthInsulin-Like Growth Factor IeducationFinlandeducation.field_of_studyTriglyceridebusiness.industryBlood pressureEndocrinologychemistryPhysical FitnessBody CompositionbusinessBody mass indexGrowth Hormone & IGF Research
researchProduct

Erythrocyte deformability in morbid obesity before bariatric surgery. Influence of abdominal obesity.

2010

Although there are several studies dealing with erythrocyte deformability (ED) in obese patients, research on this topic in morbidly obese subjects is scarce. In these studies ED seems to be decreased, although the cause remains unknown. A case-control study in 76 morbid obese subjects (23 women and 53 men, aged 44 ± 13 years) and in 79 normal-weight controls (30 women and 49 men, aged 43 ± 13 years) was undertaken. ED has been determined by ektacytometric techniques in a Rheodyn SSD, by means of the elongation index (EI) at 12, 30 and 60 Pascals, along with anthropometric, lipidic, metabolic and inflammatory parameters. EI was statistically lower in morbidly obese subjects than in controls…

AdultMalemedicine.medical_specialtyWaistPhysiologyBariatric SurgeryInsulin resistancePhysiology (medical)Internal medicineStatistical significanceErythrocyte DeformabilitymedicineErythrocyte deformabilityHumansAbdominal obesitybusiness.industryHematologyAnthropometryMiddle Agedmedicine.diseaseObesitySurgeryObesity MorbidEndocrinologyCase-Control StudiesObesity AbdominalFemalemedicine.symptomInsulin ResistanceWaist CircumferenceCardiology and Cardiovascular MedicinebusinessBody mass indexClinical hemorheology and microcirculation
researchProduct

Gender-specific anthropometric markers of adiposity, metabolic syndrome and visceral adiposity index (VAI) in patients with obstructive sleep apnea

2013

Obstructive sleep apnea often coexists with visceral adiposity and metabolic syndrome. In this study, we analysed gender-related differences in anthropometrics according to sleep apnea severity and metabolic abnormalities. In addition, the visceral adiposity index, a recently introduced marker of cardiometabolic risk, was analysed. Consecutive subjects with suspected obstructive sleep apnea (n = 528, 423 males, mean age ± standard deviation: 51.3 ± 12.8 years, body mass index: 31.0 ± 6.2 kg m(-2) ) were studied by full polysomnography (apnea-hypopnea index 43.4 ± 27.6 h(-1) ). Variables of general and visceral adiposity were measured (body mass index, neck, waist and hip circumferences, wai…

AdultMalemedicine.medical_specialtyWaistPolysomnographyCognitive NeuroscienceBlood PressurePolysomnographySettore MED/10 - Malattie Dell'Apparato Respiratorioreceiving-operator characteristic curveCardiovascular SystemBody Mass IndexBehavioral NeuroscienceInsulin resistanceInternal medicinemedicineHumansObesityAdiposityMetabolic SyndromeSex CharacteristicsSleep Apnea ObstructiveAnthropometrymedicine.diagnostic_testWaist-Hip Ratiobusiness.industryMetabolic Syndrome XSleep apneaGeneral MedicineSex CharacteristicMiddle Agedmedicine.diseaseObesityrespiratory tract diseasesObstructive sleep apneaEndocrinologyfat distributionBiological MarkerCardiologyFemalewomenWaist CircumferenceInsulin ResistanceMetabolic syndromebusinessBody mass indexBiomarkersHumanJournal of Sleep Research
researchProduct

Insulin resistance and glomerular hemodynamics in essential hypertension

2002

Insulin resistance and glomerular hemodynamics in essential hypertension. Background Arterial hypertension is an important cause of end-stage renal failure. Insulin has been shown to modify glomerular hemodynamics in hypertensive subjects. The aim of this work, therefore, was to observe the relationships between renal hemodynamics and insulin resistance in arterial hypertension. Methods Sixty-two non-diabetic hypertensive patients and 25 healthy normal subjects were studied. Renal plasma flow and the glomerular filtration fraction were determined by renoscintigraphy and the insulin sensitivity by an oral glucose test. Results Renal plasma flow in hypertensive subjects was lower than expecte…

AdultMalemedicine.medical_specialtyarterial hypertensionmedicine.medical_treatmentrenal plasma flowKidney GlomerulusRenal functionHemodynamicsBlood PressureEssential hypertensionurologic and male genital diseasesRenal Circulationinsulin-resistanceInsulin resistanceInternal medicineHumansMedicineKidneyglomerular filtration ratefiltration fractionbusiness.industryInsulinMiddle Agedmedicine.diseaseFiltration fractionmedicine.anatomical_structureEndocrinologyNephrologyRenal blood flowHypertensionFemaleInsulin ResistancebusinessKidney International
researchProduct

Islet autoantibodies in Latvian subjects with non-insulin-dependent diabetes mellitus: slow-onset type 1 diabetes or polyendocrine autoimmunity?

2006

In Latvia diabetes mellitus is diagnosed using the WHO's clinical criteria; assays for the detection of autoantibodies are not available, and hence slowly progressive autoimmune diabetes is likely to be missed. Autoantibodies against glutamic acid decarboxylase (GAD65) and protein tyrosine phosphatase (IA-2) among patients with clinically diagnosed NIDDM identify group of patients with slow-onset type 1 diabetes or LADA. The aim of this study was to estimate the risk of polyendocrine autoimmunity among clinically diagnosed NIDDM patients from Latvia. One hundred NIDDM patients and 100 healthy controls were tested for GAD65 and IA-2 autoantibodies as well as 21-hydroxylase (21-OH) and tissue…

AdultMalemedicine.medical_specialtyendocrine system diseasesAdolescentTissue transglutaminasemedicine.medical_treatmentOverweightmedicine.disease_causeAutoantigensGeneral Biochemistry Genetics and Molecular BiologyAutoimmunityDiagnosis DifferentialHistory and Philosophy of ScienceInternal medicineDiabetes mellitusmedicineHumansReceptor-Like Protein Tyrosine Phosphatases Class 8ChildPolyendocrinopathies AutoimmuneAutoantibodiesProtein Tyrosine Phosphatase Non-Receptor Type 1Type 1 diabetesbiologybusiness.industryGlutamate DecarboxylaseGeneral NeuroscienceInsulinAutoantibodynutritional and metabolic diseasesMembrane Proteinsmedicine.diseaseLatviaIsoenzymesEndocrinologyDiabetes Mellitus Type 1Child Preschoolbiology.proteinFemalemedicine.symptomProtein Tyrosine PhosphatasesbusinessBody mass indexBiomarkersAnnals of the New York Academy of Sciences
researchProduct